Metabolic Syndrome and its relationship with Psoriasis. A Bibliographical Review
DOI:
https://doi.org/10.55204/scc.v2i2.e62Keywords:
pathological mechanisms, psoriasis, metabolic syndrome, treatmentAbstract
Introduction: Psoriasis is a chronic, immune-mediated inflammatory disease, associated with both genetic and environmental factors that affects approximately 2 to 4% of the world's population. An evident relationship between psoriasis and metabolic syndrome has been demonstrated in different epidemiological publications. However, the pathological mechanisms underlying this comorbidity are unclear.
Objective: To clarify the potential mechanisms that mediate the association between psoriasis and metabolic syndrome.
Conclusions: The literature suggests that metabolic syndrome (insulin resistance, high blood pressure, hyperlipidemia and obesity) and psoriasis do not always occur together, but the presence of more than one of the risk factors for metabolic syndrome considerably increases the risk. from suffering from psoriasis and vice versa. Therefore, in addition to pharmacological management, healthy lifestyle changes will have a positive impact on the elimination or reduction of psoriasis lesions, in addition to a decrease in the chances of developing cardiovascular diseases in the future.
Downloads
References
Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: a systematic review. Sleep Med Rev. 2016;29:63-75.
Peralta C, Hamid P, Batool H, Al Achkar Z, Maximus P. Psoriasis and metabolic syndrome: comorbidities and environmental and therapeutic implications. Cureus. 2019;11(12).
Hao Y, Zhu Y juan, Zou S, Zhou P, Hu Y wen, Zhao Q xiang, et al. Metabolic syndrome and psoriasis: mechanisms and future directions. Front Immunol. 2021;12:711060.
Carbo Amoroso E, Leban V, Federico D, Williner ME, Díaz MG, Guardati MV, et al. Psoriasis y síndrome metabólico: Estudio retrospectivo sobre 22 casos. Rev Argent Dermatol. 2010;91(1):00-00.
Jiménez SB, Montoya L, Gaviria A, Gómez D, Morales L, Gallego P, et al. Prevalencia de síndrome metabólico en pacientes con psoriasis, Centro Dermatológico CES Sabaneta, abril a junio de 2012. Rev Asoc Colomb Dermatol Cir Dermatológica. 2015;23(1):30-8.
Mendoza JM, López E, Romera MG. Prevalencia de Síndrome metabólico en pacientes con psoriasis, mayores de 40 años. Rev Medica Los Postgrados Med. 2010;13(3).
Bartolo L, Valverde J, Rojas P, Vicuña D. Síndrome metabólico como factor de riesgo en adultos con psoriasis. Folia Dermatol Peru. 2012;23(2):61-6.
Mussallam S, Meza B, Elescano I. Síndrome metabólico como factor asociado a psoriasis en la consulta dermatológica: Centro Médico Naval" CMST", 2009. Folia Dermatol Peru. 2010;21(2):67-70.
Singh S, Young P, Armstrong AW. An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies. PloS One. 2017;12(7):e0181039.
Rubio-Guerra AF, Lozano-Nuevo JJ, Mariano CGL, Valdés-Solís E. Asociación entre la severidad de la psoriasis en placas y el síndrome metabólico. Med Interna México. 2016;32(2):190-200.
Milčić D, Janković S, Vesić S, Milinković M, Marinković J, Ćirković A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study. An Bras Dermatol. 2017;92:46-51.
Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5-6):231-7.
Mayoral LPC, Andrade GM, Mayoral EPC, Huerta TH, Canseco SP, Rodal Canales FJ, et al. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res. enero de 2020;151(1):11-21.
Litwin M, Kułaga Z. Obesity, metabolic syndrome, and primary hypertension. Pediatr Nephrol Berl Ger. 2021;36(4):825-37.
James BD, Jones AV, Trethewey RE, Evans RA. Obesity and metabolic syndrome in COPD: Is exercise the answer? Chron Respir Dis. mayo de 2018;15(2):173-81.
Klop B, Elte JWF, Castro Cabezas M. Dyslipidemia in Obesity: Mechanisms and Potential Targets. Nutrients. 12 de abril de 2013;5(4):1218-40.
Pallarés-Carratalá V, Pascual-Fuster V, Godoy-Rocatí D. Dislipidemia y riesgo vascular. Una revisión basada en nuevas evidencias. SEMERGEN - Med Fam. 1 de noviembre de 2015;41(8):435-45.
Lee SH, Park SY, Choi CS. Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes Metab J. enero de 2022;46(1):15-37.
Benito FG, Montero IJF, del Río Ligorit A. Prevención y tratamiento del síndrome metabólico. Rev Esp Cardiol Supl. 2005;5(4):46D-52D.
Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 23 de marzo de 2019;20(6):1475.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci. 5 de septiembre de 2019;20(18):4347.
Reid C, Griffiths CEM. Psoriasis and Treatment: Past, Present and Future Aspects. Acta Derm Venereol. 30 de enero de 2020;100(3):adv00032.
Singh S, Young P, Armstrong AW. Relationship between psoriasis and metabolic syndrome: a systematic review. G Ital Dermatol E Venereol Organo Uff Soc Ital Dermatol E Sifilogr. diciembre de 2016;151(6):663-77.
Gönül M, Tatar İ, Canpolat F, Işıl Kurmus G, Ergin C, Hekimoğlu B. Evaluation of abdominal fat index by ultrasonography and its relationship with psoriasis and metabolic syndrome. Postepy Dermatol Alergol. octubre de 2017;34(5):453-6.
Rodríguez ADR, Ojeda LV, Muñoz RM, Hernández-Mosqueira C. Efectos de programas de ejercicio físico en la calidad de vida y la condición física orientadas a la salud, en estudiantes universitarios con sobrepeso u obesidad: una revisión sistemática. Retos Nuevas Tend En Educ Física Deporte Recreación. 2023;(50):332-41.
Rodríguez-Zúñiga MJM, Cortez-Franco F, Quijano-Gomero E. Association of Psoriasis and Metabolic Syndrome in Latin America: A Systematic Review and Meta-Analysis. Actas Dermosifiliogr. mayo de 2017;108(4):326-34.
Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. marzo de 2013;31(3):433-42; discussion 442-443.
Teklu M, Zhou W, Kapoor P, Patel N, Dey AK, Sorokin AV, et al. Metabolic syndrome and its factors are associated with noncalcified coronary burden in psoriasis: An observational cohort study. J Am Acad Dermatol. mayo de 2021;84(5):1329-38.
Mathew AV, Li L, Byun J, Guo Y, Michailidis G, Jaiswal M, et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care. noviembre de 2018;41(11):2431-7.
Sequi-Dominguez I, Alvarez-Bueno C, Martinez-Vizcaino V, Fernandez-Rodriguez R, Del Saz Lara A, Cavero-Redondo I. Effectiveness of Mobile Health Interventions Promoting Physical Activity and Lifestyle Interventions to Reduce Cardiovascular Risk Among Individuals With Metabolic Syndrome: Systematic Review and Meta-Analysis. J Med Internet Res. 31 de agosto de 2020;22(8):e17790.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ruben Dario Siguencia Barrera, Carlos Rolando Espinoza Cardenas
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the moral and patrimonial rights of their works. Since Prometeo Journal is an open access publication, readers can fully or partially reproduce its content as long as they properly credit the corresponding authors and the journal itself.
Our journal is governed by the international policies SHERPA/RoMEO: Green journal: They allow the self-archiving of both the pre-print (draft of a paper) and the post-print (the version corrected and reviewed by peers) and even the final version ( layout as it will be published in the journal).
See also "Copyright and licences".
